Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Amniotic epithelial cells from the human placenta potently suppress a mouse model of multiple sclerosis.
[Sexuality of men with neurologic disorders].
Central nervous system lymphoma associated with natalizumab.
Disease exacerbation of multiple sclerosis is characterized by loss of terminally differentiated autoregulatory CD8+ T cells.
Plasma chemerin levels in patients with multiple sclerosis.
Tapered withdrawal of phenytoin removes protective effect in EAE without inflammatory rebound and mortality.
Accuracy of StepWatch™ and ActiGraph Accelerometers for Measuring Steps Taken among Persons with Multiple Sclerosis.
Treatment of progressive multiple sclerosis with pulse cyclophosphamide/methylprednisolone: response to therapy is linked to the duration of progressive disease.
MSQoL-54 predicts change in fatigue after inpatient rehabilitation for people with multiple sclerosis.
PICO, PICOS and SPIDER: a comparison study of specificity and sensitivity in three search tools for qualitative systematic reviews.
Novartis acquires all remaining rights to GSK's Ofatumumab to develop treatments for MS and other autoimmune indications
Daphnetin Alleviates Experimental Autoimmune Encephalomyelitis via Regulating Dendritic Cell Activity.
Early Treatment with Anti-VLA-4 mAb Can Prevent the Infiltration and/or Development of Pathogenic CD11b+CD4+ T Cells in the CNS during Progressive EAE.
A case of multiple sclerosis improvement following removal of heavy metal intoxication : Lessons learnt from Matteo's case.
Remote effects of intermittent theta burst stimulation of the human pharyngeal motor system.
Lack of response to pulse cyclophosphamide in neuromyelitis optica: evaluation of 7 patients.
Polyunsaturated fatty acids in multiple sclerosis therapy.
The prospects of minocycline in multiple sclerosis.
Efficacy of minocycline in acute ischemic stroke: a single-blinded, placebo-controlled trial.
Alemtuzumab 3-year data show durable effect on MS disability
New technologies for biomarker discovery in multiple sclerosis.
Revisiting The Multiple Sclerosis Functional Composite: proceedings from the National Multiple Sclerosis Society (NMSS) Task Force on Clinical Disability Measures.
The genetics of multiple sclerosis.
A Population Approach to Characterize Interferon Beta-1b Effect on Contrast Enhancing Lesions in Patients With Relapsing Remitting Multiple Sclerosis.
Neuromyelitis optica with very late onset.

Pages